Abnormal functioning of the Cystic Fibrosis (CF) Transmembrane Conductance Regulator (CFTR) channel impairs mucociliary clearance and promotes chronic bacterial infections in the lung of CF patients. Progressive lung destruction leads to lung failure, the main cause of premature death in CF patients. However, impaired CFTR functioning affects also the pancreas and the liver with well recognized gastrointestinal manifestations that often develop early in life and contribute to the clinical deterioration. Novel therapies are under evaluation in the context of the extensive research on CF liver and gastrointestinal pathophysiology. In this review, pathological mechanisms and clinical manifestations of liver disease and pancreatic insufficiency are described with attention to future therapeutic development.

Liver and Pancreatic Disease in Cystic Fibrosis : Clinics and Drug Therapy / C. Colombo, G. Alicandro, F. Corti, M. Conese. - In: CLINICAL IMMUNOLOGY, ENDOCRINE & METABOLIC DRUGS. - ISSN 2212-7070. - 3:2(2016), pp. 117-129. [10.2174/2212707004666170608094137]

Liver and Pancreatic Disease in Cystic Fibrosis : Clinics and Drug Therapy

C. Colombo
Primo
;
G. Alicandro
Secondo
;
F. Corti
Penultimo
;
2016

Abstract

Abnormal functioning of the Cystic Fibrosis (CF) Transmembrane Conductance Regulator (CFTR) channel impairs mucociliary clearance and promotes chronic bacterial infections in the lung of CF patients. Progressive lung destruction leads to lung failure, the main cause of premature death in CF patients. However, impaired CFTR functioning affects also the pancreas and the liver with well recognized gastrointestinal manifestations that often develop early in life and contribute to the clinical deterioration. Novel therapies are under evaluation in the context of the extensive research on CF liver and gastrointestinal pathophysiology. In this review, pathological mechanisms and clinical manifestations of liver disease and pancreatic insufficiency are described with attention to future therapeutic development.
cystic fibrosis; liver disease; pancreatic insufficiency; CFTR, lung failure; gastrointestinal pathophysiology
Settore MED/01 - Statistica Medica
Settore MED/38 - Pediatria Generale e Specialistica
Article (author)
File in questo prodotto:
File Dimensione Formato  
Liver and Pancreatic Disease in Cystic Fibrosis Clinics and Drug Therapy.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 2.38 MB
Formato Adobe PDF
2.38 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/524335
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact